Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.04 Billion CNY | -116.76% |
| 2022 | -481.2 Million CNY | 21.8% |
| 2021 | -615.34 Million CNY | 39.29% |
| 2020 | -1.01 Billion CNY | 48.81% |
| 2019 | -1.98 Billion CNY | -38.33% |
| 2018 | -1.43 Billion CNY | -32.32% |
| 2017 | -1.08 Billion CNY | -20.38% |
| 2016 | -898.59 Million CNY | -77.52% |
| 2015 | -506.2 Million CNY | -102.04% |
| 2014 | -250.54 Million CNY | -64.91% |
| 2013 | -151.92 Million CNY | 5.4% |
| 2012 | -160.59 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.02 Billion CNY | 1.86% |
| 2024 Q3 | -567.23 Million CNY | 25.57% |
| 2024 Q2 | -759.94 Million CNY | 25.76% |
| 2023 Q4 | -1.04 Billion CNY | -30.0% |
| 2023 Q3 | -802.4 Million CNY | -52.75% |
| 2023 Q2 | -525.28 Million CNY | 24.69% |
| 2023 FY | -1.04 Billion CNY | -116.76% |
| 2023 Q1 | -697.45 Million CNY | -44.94% |
| 2022 Q3 | -1.03 Billion CNY | 17.81% |
| 2022 Q2 | -1.26 Billion CNY | -112.32% |
| 2022 FY | -481.2 Million CNY | 21.8% |
| 2022 Q1 | -593.92 Million CNY | 3.48% |
| 2022 Q4 | -481.2 Million CNY | 53.57% |
| 2021 Q1 | -874.69 Million CNY | 18.42% |
| 2021 Q2 | -1.18 Billion CNY | -35.44% |
| 2021 Q3 | -902.31 Million CNY | 23.83% |
| 2021 Q4 | -615.34 Million CNY | 31.8% |
| 2021 FY | -615.34 Million CNY | 39.29% |
| 2020 FY | -1.01 Billion CNY | 48.81% |
| 2020 Q2 | -1.72 Billion CNY | -19.8% |
| 2020 Q3 | -860.47 Million CNY | 50.09% |
| 2020 Q4 | -1.07 Billion CNY | -24.6% |
| 2020 Q1 | -1.43 Billion CNY | 27.32% |
| 2019 FY | -1.98 Billion CNY | -38.33% |
| 2019 Q1 | 1.43 Billion CNY | 0.0% |
| 2019 Q4 | -1.98 Billion CNY | 0.0% |
| 2018 FY | -1.43 Billion CNY | -32.32% |
| 2017 Q4 | -1.08 Billion CNY | 0.0% |
| 2017 FY | -1.08 Billion CNY | -20.38% |
| 2017 Q2 | -809.81 Million CNY | 0.0% |
| 2016 Q2 | -625.28 Million CNY | 0.0% |
| 2016 Q1 | -625.28 Million CNY | -23.53% |
| 2016 FY | -898.59 Million CNY | -77.52% |
| 2016 Q3 | -898.59 Million CNY | -43.71% |
| 2016 Q4 | -898.59 Million CNY | 0.0% |
| 2015 Q1 | -237.37 Million CNY | 5.25% |
| 2015 FY | -506.2 Million CNY | -102.04% |
| 2015 Q4 | -506.2 Million CNY | 0.0% |
| 2015 Q3 | -506.2 Million CNY | -113.25% |
| 2015 Q2 | -237.37 Million CNY | 0.0% |
| 2014 Q2 | -139.25 Million CNY | 0.0% |
| 2014 Q3 | -250.54 Million CNY | -79.92% |
| 2014 Q1 | -139.25 Million CNY | 8.34% |
| 2014 Q4 | -250.54 Million CNY | 0.0% |
| 2014 FY | -250.54 Million CNY | -64.91% |
| 2013 FY | -151.92 Million CNY | 5.4% |
| 2013 Q1 | 160.59 Million CNY | 0.0% |
| 2013 Q4 | -151.92 Million CNY | 0.0% |
| 2013 Q3 | -151.92 Million CNY | 0.0% |
| 2012 FY | -160.59 Million CNY | 0.0% |